Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 316 record(s)

Req # A-2023-000241

Adverse Drug Reactions (ADRs). Report numbers: 001023474, 001022466, E2B_06010418, E2B_06007460, E2B_05997326, 001019346, E2B_00013096, E2B_05468825, E2B_03511811, E2B_03458556.

Organization: Health Canada

197 page(s)
August 2023

Req # A-2023-000242

Adverse Drug Reactions (ADRs). Report numbers: E2B_06025281, E2B_06017025, E2B_06012839, E2B_06013160, 001023840, E2B_02298052, E2B_06029716, E2B_06037365, 001023612, 001027680.

Organization: Health Canada

209 page(s)
August 2023

Req # A-2023-000260

Adverse Drug Reactions (ADRs). Report numbers: E2B_03151339, E2B_04813234, E2B_06058498, E2B_03457499, E2B_03563778, E2B_02973568, E2B_02178573, E2B_06064157, E2B_04533637, E2B_03885457.

Organization: Health Canada

501 page(s)
August 2023

Req # A-2023-000270

Adverse Drug Reactions (ADRs). Report numbers: E2B_06227887, E2B_06240780, E2B_06252990, E2B_06267210.

Organization: Health Canada

50 page(s)
August 2023

Req # A-2023-000286

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102849-204.

Organization: Health Canada

9 page(s)
August 2023

Req # A-2023-000291

Adverse Drug Reaction (ADR). Report number: E2B_06197237

Organization: Health Canada

19 page(s)
August 2023

Req # A-2023-000306

Adverse Drug Reactions (ADRs). Report numbers: E2B_06185212, 001028675, 001031054.

Organization: Health Canada

21 page(s)
August 2023

Req # A-2023-000308

Adverse Drug Reactions (ADRs) for ZOLINZA. Report numbers: E2B_02837360, E2B_02334836. ADRs for ZOSTAVAX II. Report numbers: 000631367, E2B_02854079, E2B_02822193, E2B_02833322, E2B_02941549, E2B_02968649, E2B_02989421.

Organization: Health Canada

151 page(s)
August 2023

Req # A-2023-000310

Adverse Drug Reactions (ADRs). Report numbers: 001010686, 001013451, 001014035, E2B_05829266, E2B_05877367, 001013373, 001016378, 001018340.

Organization: Health Canada

115 page(s)
August 2023

Req # A-2023-000318

Adverse Drug Reaction (ADR) for NALTREXONE. Report number: E2B_06248776. ADRs for HEPARIN. Report numbers: 001034285, 001034469.

Organization: Health Canada

23 page(s)
August 2023
Date modified: